P050007/S049: StarClose SE Vascular Closure System
FDA’s recorded scope: implementation of the sustainable ethylene oxide (SEO) cycle in Chamber 1 and Chamber 2 at Sterigenics UK
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 3 FDA records to the applicant name Abbott Vascular Devices. 1 entry is a PMA supplement. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Dec 9, 2025 to Apr 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MGB appears in 3 of the 3 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P050007, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 3200 Lakeside Dr., Santa Clara, CA, 95054. Recorded on P050007/S049, decision dated Apr 17, 2026.
FDA’s recorded scope: implementation of the sustainable ethylene oxide (SEO) cycle in Chamber 1 and Chamber 2 at Sterigenics UK
FDA’s recorded scope: a modification to the sustainable ethylene oxide (SEO) cycle previously approved for Line 1, Line 2, Line 14 and Line 15 at Synergy Health Ireland and implementation of the SEO cycle at Sterigenics Los Angeles
FDA’s recorded scope: approval for a manufacturing site located at Synergy Health AST, SRL, B13.1 Street 4, Avenue 1, Coyol Free Zone, Coyol, Alajuela, 20102, Costa Rica for sterilization.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
StarClose SE Vascular Closure SystemP050007/S049 | Abbott Vascular Devices | PMA supplement | Apr 17, 2026 | FDA |
StarClose SE Vascular Closure SystemP050007/S048 | Abbott Vascular Devices | PMA supplement | Mar 2, 2026 | FDA |
StarClose SE Vascular Surgical SystemP050007/S047 | Abbott Vascular Devices | PMA supplement | Dec 9, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.